drugset / Trial / NCT06265428
A Study to Compare DB-1303/BNT323 Versus T-DM1 in Breast Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
This study is designed to compare efficacy and safety of DB-1303/BNT323 versus T-DM1 in HER2-positive, unresectable and/or metastatic breast cancer patients previously treated with trastuzumab and taxane.
Timeline
- Start
- 2024-01-29
- Primary completion
- 2026-02
- Completion
- 2026-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TRASTUZUMAB PAMIRTECAN | Unknown | — | Intravenous |
| Subject | Trastuzumab emtansine | Other / unclassified | — | Intravenous |